The U.S. Food and Drug Administration has issued a safety communication regarding the use of Fecal Microbiota for Transplantation (FMT) and the risk of serious or life-threatening infections due to transmission of multi-drug resistant organisms (MDROs), as well as protections FDA has determined are needed for patients receiving investigational FMT. Two immunocompromised adults who received investigational FMT developed invasive bacterial infections due ...Read More »
fecal microbiota transplant
Could we work together with our bacteria to stop infection?
The benefits of antibiotics to both human and animal health are undisputed. However, as microbes have become increasingly resistant to antimicrobials and other drugs, scientists have become interested in new solutions to the growing superbug crisis, including the use of defensive microbes and fecal transplants. In new research, Oxford University scientists have developed a lab-based approach, creating positive co-dependent relationships ...Read More »
‘Poop pill’ capsule research paves the way for simpler C. difficile treatment
An Alberta-led clinical trial has shown Fecal Microbiota Transplant (FMT) is effective in treating clostridium difficile (C. difficile) infections whether delivered by colonoscopy or by swallowing capsules. The finding, published in the Journal of the American Medical Association, could revolutionize and broaden the use of FMT, which restores the healthy balance of bacteria living in the intestine by transferring a ...Read More »
Finding a less poopy solution for fecal transplant regulation
As fecal matter transplants (FMTs) continue to be more widely adopted, it is critical to have an appropriate regulatory framework in place, authors of this Policy Forum emphasize. They go on to outline key areas for improvement, compared to current regulatory approaches. The transfer of stool from one healthy donor to a recipient for recurrent Clostridium difficile infection (CDI) is ...Read More »